- Home
- COCP
as 11-15-2024 4:00pm EST
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).
| Founded: | N/A | Country: | United States |
| Employees: | N/A | City: | BOTHELL |
| Market Cap: | 18.3M | IPO Year: | N/A |
| Target Price: | $7.00 | AVG Volume (30 days): | 22.2K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.84 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.33 - $3.10 | Next Earning Date: | 11-13-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Cocrystal Pharma Inc. News
COCP Breaking Stock News: Dive into COCP Ticker-Specific Updates for Smart Investing
Simply Wall St.
3 days ago
November 2024 US Exchange Standouts: Promising Penny Stocks
GlobeNewswire
5 days ago
Cocrystal Pharma Reports Third Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
GlobeNewswire
18 days ago
Cocrystal Pharma’s Co-CEOs Highlight Pioneering Approach to Antiviral Drug Candidates Targeting Influenza and Coronaviruses as Fall Flu and COVID Season Begins
Simply Wall St.
a month ago
Here's Why We're Watching Cocrystal Pharma's (NASDAQ:COCP) Cash Burn Situation
GlobeNewswire
2 months ago
Cocrystal Pharma Advances Oral Pan-Viral Protease Inhibitor CDI-988 into Phase 1 Multiple-Ascending Dose Cohorts
GlobeNewswire
3 months ago
Cocrystal Pharma to Highlight Near-term Clinical Milestones During Presentations at Two Upcoming Investment Conferences
Zacks Small Cap Research
3 months ago
COCP: Topline Results from Phase 2a Study of CC-42344 in 2H24…
ACCESSWIRE
3 months ago
CoCrystal Pharma to Present at August 20th Virtual Investor Summit Microcap Event
Compare COCP vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "COCP Cocrystal Pharma Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.